Citation Impact
Citing Papers
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
The biomarkers of hyperprogressive disease in PD-1/PD-L1 blockage therapy
2020
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
2008
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Works of Prasanth Reddy being referenced
Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence
2019
Cost-effectiveness of sorafenib versus best supportive care in advanced renal cell carcinoma
2006